|Organization||UIC College of Pharmacy|
The University of Illinois at Chicago (UIC) College of Pharmacy is in the process of merging its two basic science departments, subject to approval by the Illinois Board of Higher Education, to create the proposed Department of Pharmaceutical Sciences. In anticipation of the merger, the College invites applications and nominations for the position of Head for this department. Located in the heart of Chicago, the College of Pharmacy is consistently ranked in the top ten nationally and is renowned for integration of its educational programs with innovative pharmacy services and cutting-edge research. With more than $347 million in annual research expenditures, UIC ranks among the leading universities in federal research funding.
The proposed merger involves two highly successful existing departments, the Department of Biopharmaceutical Sciences and the Department of Medicinal Chemistry and Pharmacognosy. If approved, the merged departments will combine the missions of the two departments and focus on advancing drug discovery and delivery and understanding of the mechanisms of drug action. The proposed merged departments will be home to 34 tenured/tenure-track faculty, 38 research/clinical/other faculty and nearly 100 graduate students. The current faculty in the department come from a variety of disciplines including pharmacology, pharmaceutics, pharmacognosy, chemistry, molecular biology, microbiology, biochemistry, toxicology, pharmacy, engineering and forensic science. The proposed merged departments will be home to a single umbrella graduate program that will offer students areas of concentration consistent with the research of the faculty.
The Department Head reports directly to the Dean of the College of Pharmacy. The position requires strong leadership; efficient oversight of department operations, recruitment/retention of department teaching and research faculty, ability to serve as an advocate for the department to the research community, and a sophisticated knowledge of the issues confronting higher education and basic science research in a public institution.
The successful candidate for Department Head will be a well-recognized leader in one of the areas of the current Departments strengths such as anti-infectives, anti-cancer, or neuroscience, or will bring new areas of research to the College, such as genomics, biotherapies, or others. Applicants must possess a PhD, PharmD or equivalent degree with postgraduate experience commensurate with the rank of tenured Professor. Applicants must have a strong record of scholarship and teaching, demonstrated effective leadership abilities, excellent interpersonal skills, and service to the profession. The successful candidate will have demonstrated commitment to recruiting and retaining an ethnically and culturally diverse faculty and staff.
The University of Illinois at Chicago is an affirmative action, equal opportunity employer that has a strong institutional commitment to the principle of diversity and is particularly interested in receiving applications from a broad spectrum of people, including members of ethnic minorities, women, veterans, and individuals with disabilities. For fullest consideration, interested applicants must submit a complete application package through the university’s online application system. The application package should include a cover letter of interest, curriculum vitae and the contact information for three professional references. The cover letter should include a description of the applicant’s research program, leadership philosophy and relevant experience. The application should be submitted through the following website:
Review of applications will begin immediately. The search will remain open until the position is filled; however, for fullest consideration completed applications should be submitted by April 1, 2019
The University of Illinois may conduct background checks on all job candidates upon acceptance of a contingent offer of employment. Background checks will be performed in compliance with the Fair Credit Reporting Act.